. Author manuscript; available in PMC: 2014 Sep 16.

Published in final edited form as: Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006627. doi: 10.1002/14651858.CD006627.pub2

Analysis 3.17. Comparison 3 ZIPRASIDONE versus OLANZAPINE, Outcome 17 Adverse effects: 2b. Cardiac effects - QTc abnormalities - change from baseline in ms.

Review: Ziprasidone versus other atypical antipsychotics for schizophrenia

Comparison: 3 ZIPRASIDONE versus OLANZAPINE

Outcome: 17 Adverse effects: 2b. Cardiac effects - QTc abnormalities - change from baseline in ms